TABLE 1.
Age-specific prevalence of HGV and anti-HEV in healthy Bolivian individuals
| Virus or antibody | No. (%) of individuals with virus or antibody who were aged (yr):
|
||
|---|---|---|---|
| ≤19 (n = 34) | 20–39 (n = 279) | ≥40 (n = 57) | |
| HGV RNA | 3 (8.8) | 42 (15.1) | 3 (5.3) |
| Anti-HEV (IgG) | 7 (20.6) | 50 (17.9) | 10 (17.5) |